Diarmuid wrote: » How widespread is this view and I presume the implications for a vaccine would be grave?https://www.google.com/amp/s/www.cnbc.com/amp/2020/07/06/immunity-to-coronavirus-is-fragile-and-short-lived-expert-warns.html
Away With The Fairies wrote: » Is there anywhere I can see how phase 1 and 2 of the trails went?
hmmm wrote: » I don't remember seeing data yet from Phase 1, but they've moved into phase 2/3 so obviously enough was seen in phase 1 to say it was safe and at least partially effective - they are testing 30,000 people in phase 3, it is hugely expensive. The animal trials data was releasedhttps://www.biorxiv.org/content/10.1101/2020.05.13.093195v1 Some data on the Phases:https://www.ox.ac.uk/news/2020-05-22-oxford-covid-19-vaccine-begin-phase-iiiii-human-trials What is particularly interesting about Oxford is that it is a platform they have been developing for years to target SARS-like Coronaviruses. Below is data for their MERS vaccine which was being developed before Covid arrived:https://www.nih.gov/news-events/news-releases/investigational-chimp-adenovirus-mers-cov-vaccine-protects-monkeys
LiquidZeb wrote: » Just wondering what the lads here think of some stories of people getting covid twice? Are they misdiagnoses, testing errors, resurgence of symptoms, or just pure freak incidents? Or does it spell bad news for a vaccine?
ACitizenErased wrote: » There's been no scientific evidence/papers on re-infection so I reckon it's issues with testing. Recent studies in rhesus macaques have backed up the fact that re-infection is not likely possible.https://directorsblog.nih.gov/2020/07/14/study-in-primates-finds-acquired-immunity-prevents-covid-19-reinfections/
LiquidZeb wrote: » Thanks very much. I don't mean to brown-nose but you're one of the best covid posters on the site. To be fair the vaccine thread is fairly solid for good posters.
hmmm wrote: » Moderna phase 1 results are out.https://www.nejm.org/doi/full/10.1056/NEJMoa2022483https://www.reuters.com/article/us-health-coronavirus-moderna/moderna-phase-one-results-show-coronavirus-vaccine-safe-induces-immune-response-idUSKCN24F2SWhttps://twitter.com/LucyWalkerlab/status/1283173961862447104 Meg is the best biotech commentator on TV. https://www.youtube.com/watch?v=BNqoa3aVFx8
hmmm wrote: » Looks like potential good news for vaccine development and protection against Covid in general. Still plenty more work to be done before we can draw conclusions.https://twitter.com/bertoletti_lab/status/1283330582923997185 "Patients recovered from #SARS 17 years ago still possess virus-specific memory T cells displaying cross-reactivity to #SARSCoV2" "3) Over 50% of donors with no infection or contact with SARSCoV1/2 harbor expandable T cells cross-reactive to #SARSCoV2 likely induced by contact or infection with other #coronavirus strains "
stevek93 wrote: » Can someone explain the T Cell immune response? I don't fully understand it.
ACitizenErased wrote: » Great interview with Sarah Gilbert who is leading the UofOxford vaccine. Covid Vaccine Front-Runner Is Months Ahead of Her Competition The University of Oxford candidate, led by Sarah Gilbert, might be through human trials in September. AstraZeneca has lined up agreements to produce 2 billion doses. Could this be the one?https://www.bloomberg.com/news/features/2020-07-15/oxford-s-covid-19-vaccine-is-the-coronavirus-front-runner?cmpid=socialflow-twitter-businessweek&utm_content=businessweek&utm_campaign=socialflow-organic&utm_medium=social&utm_source=twitter
D.Q wrote: » Can't even imagine the pressure on her shoulders. Deserves so much respect.
Hmmzis wrote: » Very solid results, overall titers are sky high, good neutralisation titers as well. The 100ug dose prime+boost looks like the best option for this vaccine. Induces some cell based responses as well. Overall, having seen now at least half a dozen RNA vaccine results (pre-clinic and clinical), to me it looks like they are doing a solid job of getting an immune response going. They might not be the nicest ones to take, but the payoff looks to be worth it. Now it's observation of the kinetics over time.
It also showed that there are, in fact, people who have both CD4+ and CD8+ T cells that recognize protein antigens from the new coronavirus even though they have never been exposed to SARS, MERS, or the new virus. The paper speculated that this might be due to cross-reactivity with proteins from the “common cold” coronaviruses”, and raised the possibility that there might be a part of the population that has at least some existing protection against the current pandemic